571 related articles for article (PubMed ID: 28545401)
1. The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression.
Neijenhuis MK; Kievit W; Perrone RD; Sloan JA; Erwin P; Murad MH; Gevers TJG; Hogan MC; Drenth JPH
BMC Nephrol; 2017 May; 18(1):169. PubMed ID: 28545401
[TBL] [Abstract][Full Text] [Related]
2. Quality of life of patients with ADPKD-Toranomon PKD QOL study: cross-sectional study.
Suwabe T; Ubara Y; Mise K; Kawada M; Hamanoue S; Sumida K; Hayami N; Hoshino J; Hiramatsu R; Yamanouchi M; Hasegawa E; Sawa N; Takaichi K
BMC Nephrol; 2013 Aug; 14():179. PubMed ID: 23978051
[TBL] [Abstract][Full Text] [Related]
3. Effect of renal transcatheter arterial embolization on quality of life in patients with autosomal dominant polycystic kidney disease.
Suwabe T; Ubara Y; Sekine A; Ueno T; Yamanouchi M; Hayami N; Hoshino J; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K
Nephrol Dial Transplant; 2017 Jul; 32(7):1176-1183. PubMed ID: 28873973
[TBL] [Abstract][Full Text] [Related]
4. Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease.
Simms RJ; Thong KM; Dworschak GC; Ong AC
Nephrol Dial Transplant; 2016 Jul; 31(7):1130-40. PubMed ID: 26268712
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.
Rizk D; Jurkovitz C; Veledar E; Bagby S; Baumgarten DA; Rahbari-Oskoui F; Steinman T; Chapman AB
Clin J Am Soc Nephrol; 2009 Mar; 4(3):560-6. PubMed ID: 19261830
[TBL] [Abstract][Full Text] [Related]
6. Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry.
van Aerts RMM; Kievit W; de Jong ME; Ahn C; Bañales JM; Reiterová J; Nevens F; Drenth JPH
Liver Int; 2019 Mar; 39(3):575-582. PubMed ID: 30225933
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin analogues improve health-related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo-controlled trials.
Neijenhuis MK; Gevers TJ; Nevens F; Hogan MC; Torres VE; Kievit W; Drenth JP
Aliment Pharmacol Ther; 2015 Sep; 42(5):591-8. PubMed ID: 26129925
[TBL] [Abstract][Full Text] [Related]
9. Is Regular Screening for Intracranial Aneurysm Necessary in Patients with Autosomal Dominant Polycystic Kidney Disease? A Systematic Review and Meta-analysis.
Zhou Z; Xu Y; Delcourt C; Shan J; Li Q; Xu J; Hackett ML
Cerebrovasc Dis; 2017; 44(1-2):75-82. PubMed ID: 28502970
[TBL] [Abstract][Full Text] [Related]
10. Quality of Life and Life Satisfaction in Former Athletes: A Systematic Review and Meta-Analysis.
Filbay S; Pandya T; Thomas B; McKay C; Adams J; Arden N
Sports Med; 2019 Nov; 49(11):1723-1738. PubMed ID: 31429036
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease.
Gevers TJ; Chrispijn M; Wetzels JF; Drenth JP
BMC Nephrol; 2012 Apr; 13():17. PubMed ID: 22475206
[TBL] [Abstract][Full Text] [Related]
12. The relationship between liver cyst volume and QOL in Japanese ADPKD patients.
Muto S; Ando M; Nishio S; Hanaoka K; Ubara Y; Narita I; Kamura K; Mochizuki T; Tsuchiya K; Tsuruya K; Horie S
Clin Exp Nephrol; 2020 Apr; 24(4):314-322. PubMed ID: 31875934
[TBL] [Abstract][Full Text] [Related]
13. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
[TBL] [Abstract][Full Text] [Related]
14. Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial.
Gevers TJ; Hol JC; Monshouwer R; Dekker HM; Wetzels JF; Drenth JP
Liver Int; 2015 May; 35(5):1607-14. PubMed ID: 25369108
[TBL] [Abstract][Full Text] [Related]
15. Impact of liver volume on polycystic liver disease-related symptoms and quality of life.
Neijenhuis MK; Kievit W; Verheesen SM; D'Agnolo HM; Gevers TJ; Drenth JP
United European Gastroenterol J; 2018 Feb; 6(1):81-88. PubMed ID: 29435317
[TBL] [Abstract][Full Text] [Related]
16. Frequency and clinical profile of patients with polycystic kidney disease in southern Brazil.
Nunes AC; Milani V; Porsch DB; Rossato LB; Mattos CB; Roisenberg I; Barros EJ
Ren Fail; 2008; 30(2):169-73. PubMed ID: 18300116
[TBL] [Abstract][Full Text] [Related]
17. Biliary Tract and Liver Complications in Polycystic Kidney Disease.
Judge PK; Harper CHS; Storey BC; Haynes R; Wilcock MJ; Staplin N; Goldacre R; Baigent C; Collier J; Goldacre M; Landray MJ; Winearls CG; Herrington WG
J Am Soc Nephrol; 2017 Sep; 28(9):2738-2748. PubMed ID: 28465378
[TBL] [Abstract][Full Text] [Related]
18. Sleep-Disordered Breathing in Patients with Polycystic Liver and Kidney Disease Referred for Transcatheter Arterial Embolization.
Sumida K; Hoshino J; Suwabe T; Kasai T; Hayami N; Mise K; Kawada M; Imafuku A; Hiramatsu R; Hasegawa E; Yamanouchi M; Sawa N; Narui K; Takaichi K; Ubara Y
Clin J Am Soc Nephrol; 2015 Jun; 10(6):949-56. PubMed ID: 25825485
[TBL] [Abstract][Full Text] [Related]
19. The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease.
D'Agnolo HMA; Casteleijn NF; Gevers TJG; de Fijter H; van Gastel MDA; Messchendorp AL; Peters DJM; Salih M; Soonawala D; Spithoven EM; Visser FW; Wetzels JFM; Zietse R; Gansevoort RT; Drenth JPH
Am J Nephrol; 2017; 46(3):239-248. PubMed ID: 28881341
[TBL] [Abstract][Full Text] [Related]
20. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M; Inci A
Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
